Heart surgery is done to correct problems with the heart. More than half a million heart surgeries are done each year in the United States for a variety of heart problems. Heart surgery is used to correct heart problems in children and adults. This article discusses heart surgeries for adults. For more information about heart surgeries for children, see the Diseases and Conditions Index articles on congenital heart defects, holes in the heart, and tetralogy of Fallot.
The most common type of heart surgery for adults is coronary artery bypass grafting (CABG). During CABG, surgeons use healthy arteries or veins taken from another part of the body to bypass (that is, go around) blocked arteries. CABG relieves chest pain and reduces the risk of heart attack.
An experimental procedure marks the launch of a research study approved by the Food and Drug Administration in January. The breakthrough technology could save the lives of thousands of people with heart valve disease who have no other treatment options. In a new clinical trial the first U.S. patient has received a heart valve implant without open-heart surgery.
Twenty five heart surgeons in Northwest England publish their individual mortality rates in this week's BMJ. The results show that all surgeons are performing to satisfactory standards.
When a young child is in need of a heart transplant, the problem is not the intricate surgery, but the scarcity of donors.
Specific variants of genes involved in inflammation and blood vessel constriction are strongly associated with kidney damage in patients undergoing major heart surgery, researchers at Duke University Medical Center have found.
The Swedish research team studied 102 women under the age of 75, all of whom had survived a heart attack or heart surgery for blocked arteries. All participants were asked to record their alcohol intake for one week after a year.
Individuals with moderate to severe chest pains (angina) who have not found relief from medication may benefit from a new gene therapy approach being used by cardiologists at Rush University Medical Center to grow new blood vessels in the heart.
In recent years, children's hospitals have joined in the national push to improve patient safety and avoid preventable problems. But it has been hard to measure progress, because of uncertainty about whether standard patient safety measurement tools apply to their patients, who are younger, smaller and on average sicker than those at other hospitals.
The Food and Drug Administration (FDA) has issued a Public Health Advisory summarizing the agency's recent recommendations concerning the use of non-steroidal anti-inflammatory drug products (NSAIDs), including those known as COX-2 selective agents.
Researchers in Aberdeen have launched a study to see whether a new blood test can better predict the outcome for patients facing heart surgery.
Since she was a young girl, Sandra Moore, 46, of Glen Ellyn, Ill., had episodes every few months when her heart started racing.
The Hospital of the University of Pennsylvania (HUP) is participating in a nationwide clinical trial of a new valve repair device that could replace major heart surgery in some patients.
Researchers at Johns Hopkins have shown that genetic testing can be effectively used to distinguish between heart failure patients who suffer from ischemic or nonischemic forms of the disease.
A unique haemodynamic (blood flow) monitoring system which will help to minimise the risk of complications during cardiovascular surgery is being developed by Leeds-based medical devices company, Medics Research Ltd.
International researchers will, for the first time, present findings from the landmark 4D trial about whether a cholesterol-reducing drug decreases the risk of heart attacks and strokes with type 2 diabetics on dialysis at the American Society of Nephrology’s 37th Annual Meeting and Scientific Exposition in St. Louis, Missouri.
The surgical future for heart patients in Canada's northlands or in isolated towns and villages, will lie increasingly in the hands of robots, says Dr. Alan Menkis.
In a discovery that could give physicians more control over the actions of medications, researchers at Duke University Medical Center have developed a novel drug pair – a potent anti-coagulant with a matched "antidote."
A standard medical practice at some of the nation's largest children's hospitals – using whole, recently donated blood for certain infant open heart surgeries – may do more harm than good.
Child heart deaths at the Bristol Royal Infirmary have fallen markedly, to below the national average, finds a study in this week's BMJ.
New German research from Heidelberg University suggests that moderate drinking cuts the rate of further narrowing after surgery to open blocked arteries. The findings are published in the current issue of Heart.
Patients who received blood platelet transfusions during coronary bypass surgery were more likely to have prolonged hospital stays, longer surgeries, more bleeding and higher risk of infection, stroke and death, according to an international study led by the Virginia Commonwealth University Medical Center.